Trinity biotech reports landmark first-day accuracy gains in cgm pre-pivotal trial

Trinity biotech's patented technology represents a paradigm shift in the global cgm market, projected to exceed $20 billion by 2029 trinity biotech's patented technology represents a paradigm shift in the global cgm market, projected to exceed $20 billion by 2029
TRIB Ratings Summary
TRIB Quant Ranking